Претраживање
Приказ резултата 11-20 од 44
MIF antagonists are anti-diabetogenic.
(Abstracts of Papers of the American Chemical Society, 2004)
Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil
(Oxford University Press, 2002)
Immunosuppressive and anti-inflammatory action of antioxidants in rat autoimmune diabetes
(Journal of Autoimmunity, 2004)
Antidiabetogenic effect of mycophenolate mofetil is associated with down-regulation of adhesive interactions and autoreactive cell activation
(Immunology of Diabetes: Autoimmune Mechanisms and the Prevention and Cure of Type 1 Diabetes, 2002)